Ronald L Goode Insider Profile
4 Followers
Ronald L Goode, Director at Hikma Pharmaceuticals, holds 12.00K shares in Hikma Pharmaceuticals (Ticker: GB:HIK). Most recently, Ronald L Goode Bought 2,000 shares of Hikma Pharmaceuticals on Aug 26, 2016 for an estimated value of 43.60K .
Ronald L Goode's Trading History
| HIKHikma Pharmaceuticals | Aug 26, 2016 | Director | Informative Buy | 43.60K | £201.24K | |||||||||||||||||||||||||||||||||||||||||||
GB:HIK Insider Shares: 12.00K (0.50%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Ronald L Goode insider profile FAQ
What is the percentage of profitable transactions made by Ronald L Goode?
The percentage of profitable transactions made by Ronald L Goode is 0%.
What is the average return per transaction made by Ronald L Goode?
The average return per transaction made by Ronald L Goode is -29.30%.
What stocks does Ronald L Goode hold?
Ronald L Goode holds: GB:HIK stocks.
What was Ronald L Goode’s latest transaction?
Ronald L Goode’s latest transaction was an Informative Buy of 43.60K .
What was Ronald L Goode's most profitable transaction?
Ronald L Goode’s most profitable transaction was an Informative Sell of GB:HIK stock on October 10, 2014. The return on the trade was -18.90%.
What is Ronald L Goode's role in Hikma Pharmaceuticals?
Ronald L Goode's role in Hikma Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
